Loading NeuroQure
NeuroQure Logo
Get Started
Get Started
  1. Patients
  2. Order Autism Detection Test

Start your request

Please read the NeuroQure Patient Information Sheet Read the NeuroQure Partners’ Consent Information

How will you be paying for the test?

If you have questions of any moment of filling out this form or need an assistance, please

Contact Us

If you have questions of any moment of filling out this form or need an assistance, please

Contact Us

Where will you have your skin biopsy

Enter your primary care provider information

Next we will ask about your health and medical history, including your family history of cancer


We collect this information to help the PWN Health physician confirm your eligibility for the NeuroQure test and help our NeuroQure lab interpret your test results.


You can review our and for additional details.

General Information

Please provide your primary reason for requesting the test.

Please choose which test situation best applies to you. For informational purposes only.

What is your child's sex assigned at birth?

What is your child's ethnicity? You may select more than one option if applicable.

Medical History

Did the child's birth mother have any serious illnesses during pregnancy

Autism History

Have any of your close family members had autism in their lifetime? By close family members, we mean your first and second degree family members (E.g. parents, grandparents, siblings, aunts, uncles, nieces, nephews, children, grandchildren)

Genetic Predisposition

Have any of your close family members had autism in their lifetime? By close family members, we mean your first and second degree family members (E.g. parents, grandparents, siblings, aunts, uncles, nieces, nephews, children, grandchildren)

If you have questions of any moment of filling out this form or need an assistance, please

Contact Us

Review your responses before the checkout process

Checkout

When your Early Autism Detection test request is submitted, you’ll be charged $949.

This price includes:

  • The Early Autism Detection test
  • Evaluation of clinical eligibility (PWNHealth oversight fee included)
  • Skin biopsy services with one of our partners
  • Sample processing at the NEUROQURE lab
  • Test results review by a PWN Health physician and optional consultations
  • Support services from the NEUROQURE Patient Advocate for you and your primary care provider in the event of a Autism
  • Signal Detected test result

If you have questions of any moment of filling out this form or need an assistance, please

Contact Us
Important Safety Information

The early Autism detection test is recommended for use in people with an elevated risk for Autism, such as newborns from those with a previous family history, or where there is concern infants are not meeting developmental milestones. The early Autism detection test does not detect all types of Autism and should be used in addition to routine Autism screening tests recommended by a healthcare provider. The early Autism detection test is intended to detect cellular biophysical signals highly correlated with diagnosis of ASD. Use of the early Autism detection test is not recommended in individuals who are pregnant or undergoing active Autism treatment.

Results should be interpreted by a healthcare provider in the context of medical history, clinical signs and symptoms. A test result of “No Autism Signal Detected” does not rule out Autism; 25% of those with ADOS-diagnosed ASD signal in the neurotypical range. The test interpretation is designed to in this fashion to minimize any false-positive results. A test result of “Autism Signal Detected” requires confirmatory medical diagnostic evaluation or by medically established procedures (e.g. ADOS) to confirm Autism.

If Autism is not clinically confirmed, it could mean that the patient is still too young to manifest symptoms or that Autism is not present or testing was insufficient to detect Autism, including due to a limited skin sample. False-positive (an autism signal detected when autism is not present) and false-negative (a autism signal not detected when autism is present) test results do occur. Rx only.

Laboratory / Test Information

NeuroQure’s clinical laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and accredited by the College of American Pathologists (CAP). The early Autism detection test was developed, and its performance characteristics were determined by NeuroQure. The early Autism detection test has not yet been cleared or approved by the Food and Drug Administration. NeuroQure’s clinical laboratory is regulated under CLIA to perform high-complexity testing. The early Autism detection test is intended for clinical purposes.

References
  1. Intracellular calcium dysregulation in autism spectrum disorder: An analysis of converging organelle signaling pathways - PubMed (nih.gov)
  2. High-throughput screen detects calcium signaling dysfunction in typical sporadic autism spectrum disorder - PubMed (nih.gov)
  3. Shared functional defect in IP₃R-mediated calcium signaling in diverse monogenic autism syndromes - PubMed (nih.gov)